FERNDEX Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Ferndex, and when can generic versions of Ferndex launch?
Ferndex is a drug marketed by Ferndale Labs and is included in one NDA.
The generic ingredient in FERNDEX is dextroamphetamine sulfate. There are eighteen drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the dextroamphetamine sulfate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Ferndex
A generic version of FERNDEX was approved as dextroamphetamine sulfate by BARR on January 31st, 2001.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for FERNDEX?
- What are the global sales for FERNDEX?
- What is Average Wholesale Price for FERNDEX?
Summary for FERNDEX
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 18 |
| DailyMed Link: | FERNDEX at DailyMed |
US Patents and Regulatory Information for FERNDEX
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ferndale Labs | FERNDEX | dextroamphetamine sulfate | TABLET;ORAL | 084001-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
